{
  "trial_id": "NCT03008005",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Able to give informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Right-handed",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age between 18-50 years old",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Physically and neurologically healthy [confirmed by a comprehensive medical history]",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Current PTSD diagnosis",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "clinically significant medical or neurologic condition or neurocognitive dysfunction",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "that would affect function and/or task performance and/or interfere with the study protocol",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "any current (or within past 2 months) medical condition requiring medication that would interact with dronabinol or interfere with the study protocol",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has Parkinson's disease, but is physically and neurologically healthy. He has a current PTSD diagnosis.",
  "_meta": {
    "topic_id": "75",
    "trial_id": "NCT03008005",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}